* Amdocs Ltd DOX.OQ DOX.O is expected to show a rise in
quarterly revenue when it reports results on January 31.
* The Chesterfield Missouri Missouri-based company is
expected to
report a 6.2% increase in revenue to $1.173 billion from $1.1
billion a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. The company's guidance on
November 8 2022, for the period ended December 31, was for
revenue between $1.16 billion and $1.20 billion.
* Refinitiv's mean analyst estimate for Amdocs Ltd is for
earnings of $1.32 per share. The company's EPS guidance on
November 8 2022, for the period ended December 31, was between
$1.29 and $1.35
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Amdocs Ltd
is
$98.5, above its last closing price of $90.38.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 1.29 1.29 1.29 Met 0
Jun. 30 2022 1.27 1.27 1.27 Met 0.3
Mar. 31 2022 1.25 1.25 1.54 Beat 23.3
Dec. 31 2021 1.18 1.18 1.20 Beat 1.4
Sep. 1.18 1.18 1.16 Missed -1.4
30 2021
Jun. 30 2021 1.19 1.18 1.35 Beat 14.4
Mar. 31 2021 1.13 1.13 1.13 Met -0.2
Dec. 31 2020 1.14 1.14 1.16 Beat 2.1
This summary was machine generated January 27 at 23:22 GMT. All
figures in US dollars unless otherwise stated